NCT01146938View on ClinicalTrials.gov

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Essential HypertensionHepatic Impairment
Interventions
DRUG

fimasartan

single administration of fimasartan 120mg

DRUG

fimasartan

single administration of fimasartan 120mg

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Kyungpook National University Hospital

OTHER

collaborator

Yonsei University

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY